← FDA Drug Approvals (Drugs@FDA)
DARIFENACIN HYDROBROMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2019-10-22
Drug application
- FDA Application #
ANDA209571- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DARIFENACIN HYDROBROMIDE
- Generic name
- Darifenacin Hydrobromide
- Active ingredients
- DARIFENACIN HYDROBROMIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- XIROMED
- First approval
- 2019-10-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown